Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1388320/000121390018001918/f8k021518_actiniumpharma.htm
SEC Filings
ATNM Annual Reports
10-K Annual Report March 2022
10-K Annual Report March 2021
10-K Annual Report May 2020
10-K Annual Report March 2019
10-K Annual Report March 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report March 2015
10-K Annual Report February 2014
10-K Annual Report March 2013
10-K Annual Report March 2022
10-K Annual Report March 2021
10-K Annual Report May 2020
10-K Annual Report March 2019
10-K Annual Report March 2018
10-K Annual Report March 2017
10-K Annual Report March 2016
10-K Annual Report March 2015
10-K Annual Report February 2014
10-K Annual Report March 2013
ATNM Quarterly Reports
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report July 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report October 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report June 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report July 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report October 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report June 2020
10-Q Quarterly Report November 2019
ATNM Corporate News
Regulated Disclosure March 2023
Financial Exhibit
Regulated Disclosure February 2023
Event for Officers
Financial Exhibit
Vote of Security Holders December 2022
Other Events December 2022
Financial Exhibit
Regulated Disclosure October 2022
Financial Exhibit
New Agreement June 2022
New Agreement April 2022
Event for Officers
Financial Exhibit
Vote of Security Holders November 2021
Event for Officers
Financial Exhibit
Regulated Disclosure September 2021
Event for Officers
Financial Exhibit
Vote of Security Holders November 2020
Regulated Disclosure
March 2023
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
February 2023
Event for Officers
Financial Exhibit
Vote of Security Holders
Financial Exhibit
Vote of Security Holders
December 2022
Other Events
December 2022
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
October 2022
Financial Exhibit
New Agreement
New Agreement
June 2022
New Agreement
April 2022
Event for Officers
Financial Exhibit
Vote of Security Holders
Financial Exhibit
Vote of Security Holders
November 2021
Event for Officers
Financial Exhibit
Regulated Disclosure
Financial Exhibit
Regulated Disclosure
September 2021
Event for Officers
Financial Exhibit
Vote of Security Holders
Financial Exhibit
Vote of Security Holders
November 2020
Last10K.com | 8-K Material Event Thu Feb 15 2018
View differences made from one to another to evaluate Actinium Pharmaceuticals, Inc.'s financial trajectory
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Actinium Pharmaceuticals, Inc..
Assess how Actinium Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy
Actinium Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Material Contracts, Statements, Certifications & more
Actinium Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
Exhibit 1.1: Dealer-Manager Agreement, Dated February 15, 2018, Between Maxim Group Llc And A
Exhibit 4.1: Form Of Warrant Agency Agreement Between Action Stock Transfer Corporation And A
Exhibit 4.2: Form Of Series A Warrant
Exhibit 4.3: Form Of Series B Warrant
Exhibit 4.4: Form Of Non-Transferable Subscription Rights Certificate
Exhibit 5.1: Legal Opinion Of The Matt Law Firm, Pllc
Exhibit 99.1: Form Of Instructions As To Use Of Subscription Rights Certificates
Exhibit 99.2: Form Of Letter To Stockholders Who Are Record Holders
Exhibit 99.3: Form Of Letter To Brokers, Dealers, Banks And Other Nominees
Exhibit 99.4: Form Of Letter To Clients Who Are Beneficial Owners
Exhibit 99.5: Form Of Beneficial Owner Election Form
Exhibit 99.6: Form Of Nominee Holder Certification
Exhibit 99.7: Form Of Notice Of Important Tax Information
Ticker: ATNMEvents:
CIK: 1388320
Form Type: 8-K Corporate News
Accession Number: 0001213900-18-001918
Submitted to the SEC: Thu Feb 15 2018 8:00:35 AM EST
Accepted by the SEC: Thu Feb 15 2018
Period: Thursday, February 15, 2018
Industry: Pharmaceutical Preparations
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/atnm/0001213900-18-001918.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...